Nanjing, China

Hai Jun Wang

USPTO Granted Patents = 19 

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 190(Granted Patents)


Location History:

  • Shenzhen, CN (2010 - 2020)
  • Nanjing, CN (2013 - 2021)
  • Jiangsu, CN (2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovation and Impact of Inventor Hai Jun Wang

Introduction

Hai Jun Wang, a distinguished inventor based in Nanjing, China, has made significant contributions to the field of pharmaceuticals through his innovative research. With a remarkable portfolio comprising 19 patents, his work primarily focuses on the development of therapeutic compounds that address various health conditions.

Latest Patents

Among his latest inventions is a groundbreaking patent titled "Compound as ACC inhibitor and use thereof." This patent discloses a novel class of compounds that function as inhibitors of acetyl-CoA carboxylase (ACC). The study outlines the methods for preparing these compounds, which include various isomers, pharmaceutically acceptable salts, solvates, crystals, or prodrugs. The pharmaceutical compositions that feature these compounds show promise for treating and preventing diseases associated with ACC expression, such as fibrotic diseases, metabolic diseases, cancers, and tissue hyperplasia diseases. The effectiveness of these compounds in inhibiting ACC presents a significant advancement in therapeutic options for these conditions.

Career Highlights

Hai Jun Wang's professional journey includes valuable experiences with prestigious companies such as Siemens and Johnson Electric International AG. His work at these organizations has enriched his expertise in the field and contributed to his innovative endeavors in patent development.

Collaborations

Throughout his career, Wang has collaborated with noteworthy professionals like Jin Jin Liu and Yu Hao Zhu. These partnerships have played a vital role in enhancing his research and expanding the reach of his inventions.

Conclusion

Hai Jun Wang exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in developing ACC inhibitors, highlight his commitment to addressing critical health issues through scientific research. With a robust portfolio of patents, Wang continues to inspire future generations of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…